Australia is closely awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://haseebwxln998454.scrappingwiki.com/2592645/retatrutide_australia_a_potential_breakthrough_for_weight_management